{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:05:37Z","timestamp":1789506337235,"version":"build-2803163510"},"reference-count":250,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["20720220004"],"award-info":[{"award-number":["20720220004"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["20720220006"],"award-info":[{"award-number":["20720220006"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2310600"],"award-info":[{"award-number":["2024YFC2310600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171821"],"award-info":[{"award-number":["82171821"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbiological Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.micres.2025.128229","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T15:23:30Z","timestamp":1747841010000},"page":"128229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Targeting HIV-1 immune escape mechanisms: Key advances and challenges in HIV-1 vaccine design"],"prefix":"10.1016","volume":"299","author":[{"given":"Zhongyue","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micres.2025.128229_bib1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.apm.2019.05.028","article-title":"The role of CD4 T cells in immune system activation and viral reproduction in a simple model for HIV infection","volume":"75","author":"Aavani PAllen","year":"2019","journal-title":"Applied Mathematical Modelling"},{"issue":"8","key":"10.1016\/j.micres.2025.128229_bib2","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.celrep.2018.07.079","article-title":"HIV-1-Infected CD4+\u2009T Cells Facilitate Latent Infection of Resting CD4+\u2009T Cells through Cell-Cell Contact","volume":"24","author":"Agosto","year":"2018","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.micres.2025.128229_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00041-24","article-title":"mRNA-based HIV-1 vaccines","volume":"37","author":"Ahmed","year":"2024","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.micres.2025.128229_bib4","first-page":"111","article-title":"Messenger RNA-Based Vaccines Against Infectious Diseases","volume":"440","author":"Alameh","year":"2022","journal-title":"Curr. Top. Microbiol Immunol."},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00002030-199002000-00002","article-title":"Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera","volume":"4","author":"Albert","year":"1990","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.micres.2025.128229_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082380","article-title":"Pre-clinical development of a recombinant, replication-competent adenovirus serotype 4 vector vaccine expressing HIV-1 envelope 1086 clade C","volume":"8","author":"Alexander","year":"2013","journal-title":"PLoS One"},{"issue":"2(2","key":"10.1016\/j.micres.2025.128229_bib7","doi-asserted-by":"crossref","first-page":"S315","DOI":"10.1086\/655654","article-title":"The humoral response to HIV-1: new insights, renewed focus","volume":"202","author":"Alter GMoody","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.micres.2025.128229_bib8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaci.2014.11.001","article-title":"The 3 major types of innate and adaptive cell-mediated effector immunity","volume":"135","author":"Annunziato","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/biom12020227","article-title":"Viral dUTPases: Modulators of Innate Immunity","volume":"12","author":"Ariza","year":"2022","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.micres.2025.128229_bib10","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41579-024-01010-8","article-title":"Immune targeting of HIV-1 reservoir cells: a path to elimination strategies and cure","volume":"22","author":"Armani-Tourret","year":"2024","journal-title":"Nat. Rev. Microbiol"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11904-011-0107-3","article-title":"The HIV-1 env protein: a coat of many colors","volume":"9","author":"Arrildt","year":"2012","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41541-021-00403-7","article-title":"Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance","volume":"6","author":"Arunachalam","year":"2021","journal-title":"NPJ Vaccin."},{"issue":"17","key":"10.1016\/j.micres.2025.128229_bib13","doi-asserted-by":"crossref","first-page":"11772","DOI":"10.1074\/jbc.M707572200","article-title":"HIV-1 Nef binds PACS-2 to assemble a multikinase cascade that triggers major histocompatibility complex class I (MHC-I) down-regulation: analysis using short interfering RNA and knock-out mice","volume":"283","author":"Atkins","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib14","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1038\/s41467-024-48139-x","article-title":"Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding","volume":"15","author":"Bai","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41598-017-18863-0","article-title":"Functional Antibody Response Against V1V2 and V3 of HIV gp120 in the VAX003 and VAX004 Vaccine Trials","volume":"8","author":"Balasubramanian","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micres.2025.128229_bib16","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3389\/fimmu.2018.01116","article-title":"Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies","volume":"9","author":"Bale","year":"2018","journal-title":"Front Immunol."},{"issue":"7","key":"10.1016\/j.micres.2025.128229_bib17","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nm.4113","article-title":"PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals","volume":"22","author":"Banga","year":"2016","journal-title":"Nat. Med"},{"issue":"4","key":"10.1016\/j.micres.2025.128229_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000891","article-title":"Complement as an Endogenous Adjuvant for Dendritic Cell-Mediated Induction of Retrovirus-Specific CTLs","volume":"6","author":"B\u00e1nki","year":"2010","journal-title":"PLOS Pathog."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib19","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41467-018-03632-y","article-title":"Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope","volume":"9","author":"Barnes","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.micres.2025.128229_bib20","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cell.2014.10.046","article-title":"Accelerating HIV-1 Vaccine Efficacy Trials","volume":"159","author":"Barouch DHMichael","year":"2014","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.micres.2025.128229_bib21","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1172\/JCI26032","article-title":"Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions","volume":"115","author":"Beignon","year":"2005","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41572-023-00452-3","article-title":"HIV infection","volume":"9","author":"Bekker","year":"2023","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"6","key":"10.1016\/j.micres.2025.128229_bib23","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0092-8674(02)01162-5","article-title":"HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway","volume":"111","author":"Blagoveshchenskaya","year":"2002","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib24","article-title":"An Update on Self-Amplifying mRNA Vaccine Development","volume":"9","author":"Blakney","year":"2021","journal-title":"Vaccin. (Basel)"},{"issue":"9","key":"10.1016\/j.micres.2025.128229_bib25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1089\/aid.2019.0239","article-title":"A Systematic Approach to HIV-1 Vaccine Immunogen Selection","volume":"36","author":"Bontempo","year":"2020","journal-title":"AIDS Res Hum. Retrovir."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1089\/dna.2021.0520","article-title":"The Importance of Cellular Immune Response to HIV: Implications for Antibody Production and Vaccine Design","volume":"41","author":"Brenna EMcMichael","year":"2022","journal-title":"DNA Cell Biol"},{"issue":"6","key":"10.1016\/j.micres.2025.128229_bib27","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.cell.2016.08.005","article-title":"Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies","volume":"166","author":"Briney","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.micres.2025.128229_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10844","article-title":"Elimination of HIV-1-infected cells by broadly neutralizing antibodies","volume":"7","author":"Bruel","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micres.2025.128229_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104254","article-title":"Immune checkpoint expression on HIV-specific CD4+\u2009T cells and response to their blockade are dependent on lineage and function","volume":"84","author":"Brunet-Ratnasingham","year":"2022","journal-title":"EBioMedicine"},{"issue":"98","key":"10.1016\/j.micres.2025.128229_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adk9550","article-title":"Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site","volume":"9","author":"Caniels","year":"2024","journal-title":"Sci. Immunol."},{"issue":"11","key":"10.1016\/j.micres.2025.128229_bib31","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.micres.2025.128229_bib32","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.tim.2019.06.002","article-title":"Molecular Mechanism of HIV-1 Entry","volume":"27","author":"Chen","year":"2019","journal-title":"Trends Microbiol"},{"issue":"8","key":"10.1016\/j.micres.2025.128229_bib33","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/febs.13954","article-title":"Structure of the transmembrane domain of HIV-1 envelope glycoprotein","volume":"284","author":"Chen BChou","year":"2017","journal-title":"FEBS J"},{"issue":"6244","key":"10.1016\/j.micres.2025.128229_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1126\/science.aaa9804","article-title":"Effect of the cytoplasmic domain on antigenic characteristics of HIV-1 envelope glycoprotein","volume":"349","author":"Chen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.micres.2025.128229_bib35","article-title":"The reservoir of latent HIV","volume":"12","author":"Chen","year":"2022","journal-title":"Front Cell Infect. Microbiol"},{"issue":"10","key":"10.1016\/j.micres.2025.128229_bib36","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.4049\/jimmunol.1002828","article-title":"CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses","volume":"186","author":"Chevalier","year":"2011","journal-title":"J. Immunol."},{"issue":"7947","key":"10.1016\/j.micres.2025.128229_bib37","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/d41586-022-04492-9","article-title":"Silence, escape and survival drive the persistence of HIV","volume":"614","author":"Chomont","year":"2023","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.micres.2025.128229_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02268-16","article-title":"Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity","volume":"91","author":"Chuang","year":"2017","journal-title":"J. Virol."},{"issue":"697","key":"10.1016\/j.micres.2025.128229_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adf3309","article-title":"A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses","volume":"15","author":"Cohen","year":"2023","journal-title":"Sci. Transl. Med"},{"issue":"4","key":"10.1016\/j.micres.2025.128229_bib40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.chom.2020.03.014","article-title":"The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies","volume":"27","author":"Cohn","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10.1016\/j.micres.2025.128229_bib41","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nrmicro2223","article-title":"Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs","volume":"7","author":"Coiras","year":"2009","journal-title":"Nat. Rev. Microbiol"},{"issue":"8","key":"10.1016\/j.micres.2025.128229_bib42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-020-0274-9","article-title":"CD8(+) T cells in HIV control, cure and prevention","volume":"20","author":"Collins","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micres.2025.128229_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0065-2776(06)94002-4","article-title":"DNA deamination in immunity: AID in the context of its APOBEC relatives","volume":"94","author":"Conticello","year":"2007","journal-title":"Adv. Immunol."},{"issue":"748","key":"10.1016\/j.micres.2025.128229_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adn0223","article-title":"Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice","volume":"16","author":"Cottrell","year":"2024","journal-title":"Sci. Transl. Med"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/viro.1996.8419","article-title":"Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa","volume":"229","author":"Cranage","year":"1997","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.micres.2025.128229_bib46","first-page":"4153","article-title":"Deoxyuridine in DNA has an inhibitory and promutagenic effect on RNA transcription by diverse RNA polymerases","volume":"47","author":"Cui","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"10.1016\/j.micres.2025.128229_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00012-17","article-title":"Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition","volume":"91","author":"Cummins","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2025.128229_bib48","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev-med-092112-152941","article-title":"Understanding HIV latency: the road to an HIV cure","volume":"66","author":"Dahabieh","year":"2015","journal-title":"Annu Rev. Med"},{"issue":"7989","key":"10.1016\/j.micres.2025.128229_bib49","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41586-023-06639-8","article-title":"Intermediate conformations of CD4-bound HIV-1 Env heterotrimers","volume":"623","author":"Dam","year":"2023","journal-title":"Nature"},{"issue":"5090","key":"10.1016\/j.micres.2025.128229_bib50","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1126\/science.1470917","article-title":"Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene","volume":"258","author":"Daniel","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.micres.2025.128229_bib51","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/978-1-4614-1680-7_13","article-title":"The evolution of adaptive immunity","volume":"738","author":"Danilova","year":"2012","journal-title":"Adv. Exp. Med Biol."},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib52","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.coviro.2013.03.014","article-title":"HIV-1 reverse transcriptase and antiviral drug resistance. Part 2","volume":"3","author":"Das","year":"2013","journal-title":"Curr Opin Virol"},{"issue":"10","key":"10.1016\/j.micres.2025.128229_bib53","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.4049\/jimmunol.1102756","article-title":"Ministry of Public Health-Thai AVEGC. The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope","volume":"188","author":"De Souza","year":"2012","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.micres.2025.128229_bib54","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.tim.2022.02.004","article-title":"Glycans in HIV-1 vaccine design - engaging the shield","volume":"30","author":"Deimel","year":"2022","journal-title":"Trends Microbiol."},{"issue":"12","key":"10.1016\/j.micres.2025.128229_bib55","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.celrep.2019.08.037","article-title":"Mapping the Lineage Relationship between CXCR5(+) and CXCR5(-) CD4(+) T Cells in HIV-Infected Human Lymph Nodes","volume":"28","author":"Del Alcazar","year":"2019","journal-title":"Cell Rep."},{"issue":"33","key":"10.1016\/j.micres.2025.128229_bib56","doi-asserted-by":"crossref","first-page":"E6932","DOI":"10.1073\/pnas.1700247114","article-title":"Distinct functions of diaphanous-related formins regulate HIV-1 uncoating and transport","volume":"114","author":"Delaney","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"49","key":"10.1016\/j.micres.2025.128229_bib57","doi-asserted-by":"crossref","first-page":"51545","DOI":"10.1074\/jbc.M408573200","article-title":"Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase","volume":"279","author":"Diamond","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micres.2025.128229_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/srep37021","article-title":"HIV-1 Nef sequesters MHC-I intracellularly by targeting early stages of endocytosis and recycling","volume":"6","author":"Dirk","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib59","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/s41467-022-28307-7","article-title":"Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells","volume":"13","author":"Dufloo","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006182","article-title":"Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial","volume":"13","author":"Easterhoff","year":"2017","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.micres.2025.128229_bib61","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.it.2021.06.003","article-title":"CD4(+) T cells that help B cells - a proposal for uniform nomenclature","volume":"42","author":"Eisenbarth","year":"2021","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.micres.2025.128229_bib62","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/nar\/gkt974","article-title":"Vpr expression abolishes the capacity of HIV-1 infected cells to repair uracilated DNA","volume":"42","author":"Eldin","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.micres.2025.128229_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2019.12.006","article-title":"Activation-induced surface proteins in the identification of antigen-responsive CD4 T cells","volume":"219","author":"Elias","year":"2020","journal-title":"Immunol. Lett."},{"issue":"11","key":"10.1016\/j.micres.2025.128229_bib64","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/j.drudis.2021.06.008","article-title":"Methods to improve the immunogenicity of plasmid DNA vaccines","volume":"26","author":"Eusebio","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"5","key":"10.1016\/j.micres.2025.128229_bib65","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.immuni.2014.04.009","article-title":"Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers","volume":"40","author":"Falkowska","year":"2014","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib66","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/imr.12823","article-title":"T-cell exhaustion in HIV infection","volume":"292","author":"Fenwick","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.micres.2025.128229_bib67","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3389\/fimmu.2018.02290","article-title":"NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies","volume":"9","author":"Florez-Alvarez","year":"2018","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.micres.2025.128229_bib68","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/428404","article-title":"Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection","volume":"191","author":"Flynn","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.micres.2025.128229_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.biochem.67.1.1","article-title":"HIV-1: fifteen proteins and an RNA","volume":"67","author":"Frankel ADYoung","year":"1998","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib70","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1038\/s41467-021-27075-0","article-title":"Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization","volume":"12","author":"Friedrich","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib71","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41467-019-08798-7","article-title":"PD-1 blockade potentiates HIV latency reversal ex vivo in CD4(+) T cells from ART-suppressed individuals","volume":"10","author":"Fromentin","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.micres.2025.128229_bib72","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.jaad.2015.11.043","article-title":"Use of tumor necrosis factor (TNF) inhibitors in patients with HIV\/AIDS","volume":"74","author":"Gallitano","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.micres.2025.128229_bib73","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2014.06.022","article-title":"Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies","volume":"158","author":"Gao","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib74","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1074\/jbc.M112.424432","article-title":"Designing a soluble near full-length HIV-1 gp41 trimer","volume":"288","author":"Gao","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib75","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.chom.2017.07.012","article-title":"Ten Strategies of Interferon Evasion by Viruses","volume":"22","author":"Garcia-Sastre","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib76","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12468","article-title":"A journey through the lectin pathway of complement-MBL and beyond","volume":"274","author":"Garred","year":"2016","journal-title":"Immunol. Rev."},{"issue":"9","key":"10.1016\/j.micres.2025.128229_bib77","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1128\/JVI.02407-10","article-title":"Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge","volume":"85","author":"Geisbert","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2025.128229_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2016.199","article-title":"An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability","volume":"2","author":"van Gils","year":"2016","journal-title":"Nat. Microbiol"},{"issue":"4","key":"10.1016\/j.micres.2025.128229_bib79","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1021\/acsnano.3c07678","article-title":"HIV-1 Capsid Uncoating Is a Multistep Process That Proceeds through Defect Formation Followed by Disassembly of the Capsid Lattice","volume":"18","author":"Gifford LBMelikyan","year":"2024","journal-title":"ACS Nano"},{"issue":"37","key":"10.1016\/j.micres.2025.128229_bib80","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1016\/j.vaccine.2011.06.085","article-title":"Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review","volume":"29","author":"Girard","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.micres.2025.128229_bib81","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.clim.2013.01.004","article-title":"R. Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity","volume":"146","author":"Goudy","year":"2013","journal-title":"Clin. Immunol."},{"issue":"7","key":"10.1016\/j.micres.2025.128229_bib82","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1473-3099(11)70098-6","article-title":"team HPs. Safety and efficacy of the HVTN 503\/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study","volume":"11","author":"Gray","year":"2011","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.micres.2025.128229_bib83","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/COH.0b013e32833d2d2b","article-title":"Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag\/pol\/nef subtype B HIV vaccine","volume":"5","author":"Gray","year":"2010","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.micres.2025.128229_bib84","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.semcdb.2014.03.030","article-title":"Cellular regulation of ribonucleotide reductase in eukaryotes","volume":"30","author":"Guarino","year":"2014","journal-title":"Semin Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.micres.2025.128229_bib85","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/s41590-019-0447-5","article-title":"CD4(+) T cell signatures in HIV infection","volume":"20","author":"Gubser","year":"2019","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.micres.2025.128229_bib86","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20240604","article-title":"Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies","volume":"221","author":"Hahn","year":"2024","journal-title":"J. Exp. Med"},{"issue":"22","key":"10.1016\/j.micres.2025.128229_bib87","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","article-title":"Team HS. Efficacy trial of a DNA\/rAd5 HIV-1 preventive vaccine","volume":"369","author":"Hammer","year":"2013","journal-title":"N. Engl. J. Med"},{"issue":"7348","key":"10.1016\/j.micres.2025.128229_bib88","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine","volume":"473","author":"Hansen","year":"2011","journal-title":"Nature"},{"issue":"7469","key":"10.1016\/j.micres.2025.128229_bib89","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature12519","article-title":"Immune clearance of highly pathogenic SIV infection","volume":"502","author":"Hansen","year":"2013","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.micres.2025.128229_bib90","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nri2575","article-title":"MHC class I antigen presentation: learning from viral evasion strategies","volume":"9","author":"Hansen THBouvier","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.micres.2025.128229_bib91","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41577-022-00753-w","article-title":"Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies","volume":"23","author":"Haynes","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.micres.2025.128229_bib92","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41577-022-00753-w","article-title":"Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies","volume":"23","author":"Haynes","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.micres.2025.128229_bib93","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1016\/j.immuni.2023.07.003","article-title":"Heavy-chain CDR3-engineered B cells facilitate in vivo evaluation of HIV-1 vaccine candidates","volume":"56","author":"He","year":"2023","journal-title":"Immunity"},{"issue":"13","key":"10.1016\/j.micres.2025.128229_bib94","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1056\/NEJMoa2107659","article-title":"nCo VSG. Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine","volume":"385","author":"Heath","year":"2021","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.micres.2025.128229_bib95","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coi.2019.02.009","article-title":"Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine","volume":"59","author":"Heineman","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.micres.2025.128229_bib96","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12977-015-0198-9","article-title":"dUTPase: the frequently overlooked enzyme encoded by many retroviruses","volume":"12","author":"Hizi","year":"2015","journal-title":"Retrovirology"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib97","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1038\/s41467-024-47905-1","article-title":"Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials","volume":"15","author":"Ho","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib98","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s44298-023-00002-4","article-title":"An HIV-1 broadly neutralizing antibody overcomes structural and dynamic variation through highly focused epitope targeting","volume":"1","author":"Hodge","year":"2023","journal-title":"Npj Virus"},{"issue":"3","key":"10.1016\/j.micres.2025.128229_bib99","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.it.2015.01.004","article-title":"Interferons and viruses: an evolutionary arms race of molecular interactions","volume":"36","author":"Hoffmann","year":"2015","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.micres.2025.128229_bib100","article-title":"Human Immunodeficiency Virus Type-1 (HIV-1) Transcriptional Regulation, Latency and Therapy in the Central Nervous System","volume":"9","author":"Hokello","year":"2021","journal-title":"Vaccin. (Basel)"},{"issue":"6","key":"10.1016\/j.micres.2025.128229_bib101","doi-asserted-by":"crossref","DOI":"10.1038\/nri1862","article-title":"CCL3 and CCL4 actively recruit CD8+\u2009T cells","volume":"6","author":"Honey","year":"2006","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.micres.2025.128229_bib102","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.cell.2017.06.048","article-title":"Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo","volume":"170","author":"Horwitz","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.micres.2025.128229_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101477","article-title":"Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial","volume":"48","author":"Houser","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"37","key":"10.1016\/j.micres.2025.128229_bib104","doi-asserted-by":"crossref","first-page":"13439","DOI":"10.1073\/pnas.1400446111","article-title":"Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals","volume":"111","author":"Hu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.micres.2025.128229_bib105","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211574","article-title":"TGF-beta regulates the stem-like state of PD-1+\u2009TCF-1+\u2009virus-specific CD8 T cells during chronic infection","volume":"219","author":"Hu","year":"2022","journal-title":"J. Exp. Med"},{"issue":"10","key":"10.1016\/j.micres.2025.128229_bib106","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.4049\/jimmunol.1600697","article-title":"DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV","volume":"197","author":"Hu","year":"2016","journal-title":"J. Immunol."},{"issue":"6280","key":"10.1016\/j.micres.2025.128229_bib107","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1126\/science.aad9195","article-title":"HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen","volume":"351","author":"Jardine","year":"2016","journal-title":"Science"},{"issue":"6244","key":"10.1016\/j.micres.2025.128229_bib108","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1126\/science.aac5894","article-title":"Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen","volume":"349","author":"Jardine","year":"2015","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.micres.2025.128229_bib109","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02686-23","article-title":"Alternative substitutions of N332 in HIV-1AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting the V3-glycan","volume":"15","author":"Jeffy","year":"2024","journal-title":"mBio"},{"issue":"11","key":"10.1016\/j.micres.2025.128229_bib110","doi-asserted-by":"crossref","first-page":"9069","DOI":"10.1128\/JVI.72.11.9069-9078.1998","article-title":"Oral immunization of macaques with attenuated vaccine virus induces protection against vaginally transmitted AIDS","volume":"72","author":"Joag","year":"1998","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.micres.2025.128229_bib111","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.celrep.2017.11.016","article-title":"Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains","volume":"21","author":"Joyce","year":"2017","journal-title":"Cell Rep."},{"issue":"18","key":"10.1016\/j.micres.2025.128229_bib112","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.180819","article-title":"Team HIVVTNS. Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119","volume":"9","author":"Kalams","year":"2024","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.micres.2025.128229_bib113","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/infdis\/jit236","article-title":"Network NHVT. Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery","volume":"208","author":"Kalams","year":"2013","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029231","article-title":"Network NHVT. Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and\/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults","volume":"7","author":"Kalams","year":"2012","journal-title":"PLoS One"},{"issue":"12 2","key":"10.1016\/j.micres.2025.128229_bib115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/infdis\/jiaa333","article-title":"The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts","volume":"223","author":"Kaseke","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.micres.2025.128229_bib116","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2165\/00003495-200363100-00006","article-title":"Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B","volume":"63","author":"Keating","year":"2003","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib117","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/imr.12513","article-title":"Genetic and structural analyses of affinity maturation in the humoral response to HIV-1","volume":"275","author":"Kepler","year":"2017","journal-title":"Immunol Rev"},{"issue":"8","key":"10.1016\/j.micres.2025.128229_bib118","article-title":"Role of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis","volume":"13","author":"Khan NGeiger","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.micres.2025.128229_bib119","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev-med-052912-123749","article-title":"Lessons from the RV144 Thai phase III HIV-1 vaccine trial and the search for correlates of protection","volume":"66","author":"Kim","year":"2015","journal-title":"Annu Rev. Med"},{"issue":"7","key":"10.1016\/j.micres.2025.128229_bib120","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0167-5699(98)01288-2","article-title":"Cytotoxic T lymphocytes in HIV-1 infection: a killing paradox?","volume":"19","author":"Klein","year":"1998","journal-title":"Immunol. Today"},{"key":"10.1016\/j.micres.2025.128229_bib121","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12040","article-title":"Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability","volume":"7","author":"Kong","year":"2016","journal-title":"Nat. Commun."},{"issue":"6287","key":"10.1016\/j.micres.2025.128229_bib122","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1126\/science.aae0474","article-title":"Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody","volume":"352","author":"Kong","year":"2016","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.micres.2025.128229_bib123","first-page":"713","article-title":"T cell-based strategies for HIV-1 vaccines. Hum Vaccin","volume":"16","author":"Korber","year":"2020","journal-title":"Immunother"},{"issue":"3","key":"10.1016\/j.micres.2025.128229_bib124","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231511","article-title":"CD4+\u2009T cells with latent HIV-1 have reduced proliferative responses to T cell receptor stimulation","volume":"221","author":"Kufera","year":"2024","journal-title":"J. Exp. Med"},{"issue":"3","key":"10.1016\/j.micres.2025.128229_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060245","article-title":"HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice","volume":"8","author":"Kulkarni","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086254","article-title":"Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques","volume":"9","author":"Kulkarni","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.micres.2025.128229_bib127","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1021\/acsomega.2c07933","article-title":"An Overview of Human Anti-HIV-1 Neutralizing Antibodies against Diverse Epitopes of HIV-1","volume":"8","author":"Kumar","year":"2023","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/j.micres.2025.128229_bib128","first-page":"208","article-title":"Protective and detrimental roles of IL-10 in HIV pathogenesis","volume":"21","author":"Kwon DSKaufmann","year":"2010","journal-title":"Eur Cytokine Netw"},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib129","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nri.2015.10","article-title":"The multifaceted role of CD4(+) T cells in CD8(+) T cell memory","volume":"16","author":"Laidlaw","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.micres.2025.128229_bib130","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41590-024-01852-7","article-title":"Germline-targeting immunogens guide bnAb development","volume":"25","author":"Lanz","year":"2024","journal-title":"Nat. Immunol."},{"issue":"6623","key":"10.1016\/j.micres.2025.128229_bib131","doi-asserted-by":"crossref","DOI":"10.1126\/science.add6502","article-title":"Vaccination induces HIV broadly neutralizing antibody precursors in humans","volume":"378","author":"Leggat","year":"2022","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib132","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1038\/s41467-020-17753-w","article-title":"Clearance of HIV infection by selective elimination of host cells capable of producing HIV","volume":"11","author":"Li","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.micres.2025.128229_bib133","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi4162","article-title":"Enhanced NF-kappaB activation via HIV-1 Tat-TRAF6 cross-talk","volume":"10","author":"Li","year":"2024","journal-title":"Sci. Adv."},{"issue":"7989","key":"10.1016\/j.micres.2025.128229_bib134","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s41586-023-06762-6","article-title":"HIV-1 Env trimers asymmetrically engage CD4 receptors in membranes","volume":"623","author":"Li","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib135","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1038\/s41467-023-38573-8","article-title":"Molecular basis of differential HLA class I-restricted T cell recognition of a highly networked HIV peptide","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"issue":"7446","key":"10.1016\/j.micres.2025.128229_bib136","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature12053","article-title":"Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus","volume":"496","author":"Liao","year":"2013","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.micres.2025.128229_bib137","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1089\/0889222041524661","article-title":"Evaluation of the safety, immunogenicity, and protective efficacy of whole inactivated simian immunodeficiency virus (SIV) vaccines with conformationally and functionally intact envelope glycoproteins","volume":"20","author":"Lifson","year":"2004","journal-title":"AIDS Res Hum. Retrovir."},{"issue":"4","key":"10.1016\/j.micres.2025.128229_bib138","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41577-021-00577-0","article-title":"Regulation of the nucleic acid-sensing Toll-like receptors","volume":"22","author":"Lind","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micres.2025.128229_bib139","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fimmu.2016.00192","article-title":"Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune Suppression","volume":"7","author":"Lopez-Abente","year":"2016","journal-title":"Front Immunol."},{"key":"10.1016\/j.micres.2025.128229_bib140","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fonc.2013.00294","article-title":"Searching for the Achilles Heel of FOXP3","volume":"3","author":"Lozano","year":"2013","journal-title":"Front Oncol."},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib141","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrmicro.2016.162","article-title":"Nuclear landscape of HIV-1 infection and integration","volume":"15","author":"Lusic MSiliciano","year":"2017","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib142","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/14760584.2023.2184803","article-title":"The quest for an HIV-1 vaccine: will mRNA deliver us from evil?","volume":"22","author":"Lusso","year":"2023","journal-title":"Expert Rev. Vaccin."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib143","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41579-021-00586-9","article-title":"Structure and function of retroviral integrase","volume":"20","author":"Maertens","year":"2022","journal-title":"Nat. Rev. Microbiol"},{"issue":"15","key":"10.1016\/j.micres.2025.128229_bib144","doi-asserted-by":"crossref","first-page":"7039","DOI":"10.1128\/JVI.74.15.7039-7047.2000","article-title":"The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate","volume":"74","author":"Mansky","year":"2000","journal-title":"J. Virol."},{"issue":"29","key":"10.1016\/j.micres.2025.128229_bib145","doi-asserted-by":"crossref","first-page":"11970","DOI":"10.1073\/pnas.1302090110","article-title":"Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 stimulation","volume":"110","author":"Marras","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib146","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/imr.12071","article-title":"Immunogenetics of HIV disease","volume":"254","author":"Martin MPCarrington","year":"2013","journal-title":"Immunol Rev"},{"issue":"22","key":"10.1016\/j.micres.2025.128229_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2024.168815","article-title":"HIV-1 Reverse Transcriptase Error Rates and Transcriptional Thresholds Based on Single-strand Consensus Sequencing of Target RNA Derived From In Vitro-transcription and HIV-infected Cells","volume":"436","author":"Martinez Del Rio","year":"2024","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.micres.2025.128229_bib148","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3389\/fimmu.2020.01112","article-title":"The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies","volume":"11","author":"Martinsen","year":"2020","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib149","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41577-023-00926-1","article-title":"A guide to complement biology, pathology and therapeutic opportunity","volume":"24","author":"Mastellos","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.micres.2025.128229_bib150","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41576-021-00378-0","article-title":"HIV-1 and human genetic variation","volume":"22","author":"McLaren","year":"2021","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.micres.2025.128229_bib151","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/nm.3413","article-title":"Another HIV vaccine failure: where to next?","volume":"19","author":"McMichael","year":"2013","journal-title":"Nature Medicine"},{"issue":"12","key":"10.1016\/j.micres.2025.128229_bib152","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009101","article-title":"RV144 HIV-1 vaccination impacts post-infection antibody responses","volume":"16","author":"Mdluli","year":"2020","journal-title":"PLoS Pathog."},{"issue":"7164","key":"10.1016\/j.micres.2025.128229_bib153","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nature06246","article-title":"Recognition of microorganisms and activation of the immune response","volume":"449","author":"Medzhitov","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib154","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/infdis\/jiac260","article-title":"Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk","volume":"226","author":"Moodie","year":"2022","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib155","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aag0851","article-title":"Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies","volume":"1","author":"Moody","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.micres.2025.128229_bib156","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.omtm.2018.10.010","article-title":"Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA","volume":"12","author":"Moyo","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"11","key":"10.1016\/j.micres.2025.128229_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110514","article-title":"mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice","volume":"38","author":"Mu","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib158","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-virology-020922-110929","article-title":"Nuclear Capsid Uncoating and Reverse Transcription of HIV-1","volume":"9","author":"Muller","year":"2022","journal-title":"Annu Rev. Virol."},{"key":"10.1016\/j.micres.2025.128229_bib159","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-3-030-67452-6_3","article-title":"Innate Immune Response Against HIV-1","volume":"1313","author":"Murugaiah","year":"2021","journal-title":"Adv. Exp. Med Biol."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib160","doi-asserted-by":"crossref","DOI":"10.1186\/1742-4690-10-1","article-title":"Attenuation of multiple Nef functions in HIV-1 elite controllers","volume":"10","author":"Mwimanzi","year":"2013","journal-title":"Retrovirology"},{"issue":"8","key":"10.1016\/j.micres.2025.128229_bib161","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.4049\/jimmunol.1301482","article-title":"HIV-1 gp120 induces TLR2- and TLR4-mediated innate immune activation in human female genital epithelium","volume":"191","author":"Nazli","year":"2013","journal-title":"J. Immunol."},{"issue":"98","key":"10.1016\/j.micres.2025.128229_bib162","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adm7097","article-title":"Immunization with germ line-targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaques","volume":"9","author":"Nelson","year":"2024","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib163","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1038\/s41467-023-40321-x","article-title":"Structures and immune recognition of Env trimers from two Asia prevalent HIV-1 CRFs","volume":"14","author":"Niu","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib164","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12250-019-00095-3","article-title":"Multiple roles of HIV-1 capsid during the virus replication cycle","volume":"34","author":"Novikova","year":"2019","journal-title":"Virol. Sin."},{"issue":"10","key":"10.1016\/j.micres.2025.128229_bib165","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/nsmb.1495","article-title":"Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase","volume":"15","author":"Nowarski","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"4","key":"10.1016\/j.micres.2025.128229_bib166","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/rmv.1739","article-title":"Comparing HIV-1 and HIV-2 infection: lessons for viral immunopathogenesis","volume":"23","author":"Nyamweya","year":"2013","journal-title":"Rev. Med Virol."},{"issue":"14","key":"10.1016\/j.micres.2025.128229_bib167","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJMp048180","article-title":"The Cutter incident, 50 years later","volume":"352","author":"Offit","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.micres.2025.128229_bib168","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41422-020-0324-7","article-title":"Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases","volume":"30","author":"Ohkura NSakaguchi","year":"2020","journal-title":"Cell Res"},{"issue":"23","key":"10.1016\/j.micres.2025.128229_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2023.168297","article-title":"DNA vaccines: history, molecular mechanisms and future perspectives","volume":"435","author":"Pagliari","year":"2023","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imr.12079","article-title":"HIV-associated chronic immune activation","volume":"254","author":"Paiardini","year":"2013","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib171","doi-asserted-by":"crossref","first-page":"a016246","DOI":"10.1101\/cshperspect.a016246","article-title":"Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors","volume":"7","author":"Pandey","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"11","key":"10.1016\/j.micres.2025.128229_bib172","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases - advances, challenges and opportunities","volume":"23","author":"Pardi NKrammer","year":"2024","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib173","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1038\/s41467-024-51656-4","article-title":"Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted\/founder sensitivity to broadly neutralizing antibodies","volume":"15","author":"Parthasarathy","year":"2024","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.micres.2025.128229_bib174","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41576-022-00459-8","article-title":"Functions and consequences of AID\/APOBEC-mediated DNA and RNA deamination","volume":"23","author":"Pecori","year":"2022","journal-title":"Nat. Rev. Genet"},{"issue":"730","key":"10.1016\/j.micres.2025.128229_bib175","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh9039","article-title":"Antibodies targeting the fusion peptide on the HIV envelope provide protection to rhesus macaques against mucosal SHIV challenge","volume":"16","author":"Pegu","year":"2024","journal-title":"Sci. Transl. Med"},{"issue":"5739","key":"10.1016\/j.micres.2025.128229_bib176","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1113401","article-title":"Toll-like receptor 8-mediated reversal of CD4+\u2009regulatory T cell function","volume":"309","author":"Peng","year":"2005","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib177","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1038\/s41467-020-16165-0","article-title":"Structural basis of transmembrane coupling of the HIV-1 envelope glycoprotein","volume":"11","author":"Piai","year":"2020","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.micres.2025.128229_bib178","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/508748","article-title":"Bangkok VAccine Evaluation G. Randomized, Double-blind, Placebo-controlled Efficacy Trial of A Bivalent Recombinant Glycoprotein 120 Hiv-1 Vaccine among Injection Drug Users in Bangkok, Thailand","volume":"194","author":"Pitisuttithum","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"S1","key":"10.1016\/j.micres.2025.128229_bib179","doi-asserted-by":"crossref","DOI":"10.1089\/aid.2014.5592.abstract","article-title":"RV306, an evaluation of a 48 week ALVAC-HIV AIDSVAX B\/E vaccination regimen in thailand: participation rates for optional specimen collections","volume":"30","author":"Pitisuttithum","year":"2014","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard AJBijker","year":"2021","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"10.1016\/j.micres.2025.128229_bib181","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jaip.2022.04.036","article-title":"Immunogenomics of killer cell immunoglobulin-like receptor (KIR) and HLA class I: coevolution and consequences for human health","volume":"10","author":"Pollock","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pr."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib182","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11904-011-0106-4","article-title":"Role of PD-1 in HIV pathogenesis and as target for therapy","volume":"9","author":"Porichis FKaufmann","year":"2012","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"6","key":"10.1016\/j.micres.2025.128229_bib183","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005005","article-title":"Complement-opsonized HIV-1 overcomes restriction in dendritic cells","volume":"11","author":"Posch","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micres.2025.128229_bib184","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1054-3589(07)55002-7","article-title":"Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors","volume":"55","author":"Prabakaran","year":"2007","journal-title":"Adv. Pharm."},{"key":"10.1016\/j.micres.2025.128229_bib185","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.633776","article-title":"A guide to nucleic acid vaccines in the prevention and treatment of infectious diseases and cancers: from basic principles to current applications","volume":"9","author":"Qin","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.micres.2025.128229_bib186","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.559792","article-title":"From entry to egress: strategic exploitation of the cellular processes by HIV-1","volume":"11","author":"Ramdas","year":"2020","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib187","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115582","article-title":"Identification of immunodominant CD4-restricted epitopes co-located with antibody binding sites in individuals vaccinated with ALVAC-HIV and AIDSVAX B\/E","volume":"10","author":"Ratto-Kim","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.micres.2025.128229_bib188","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/s41590-024-01844-7","article-title":"Affinity gaps among B cells in germinal centers drive the selection of MPER precursors","volume":"25","author":"Ray","year":"2024","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.micres.2025.128229_bib189","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41594-022-00887-4","article-title":"HIV-1 is dependent on its immature lattice to recruit IP6 for mature capsid assembly","volume":"30","author":"Renner","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"8","key":"10.1016\/j.micres.2025.128229_bib190","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/infdis\/jix099","article-title":"Team RVS. Randomized, double-blind evaluation of late boost strategies for HIV-uninfected vaccine recipients in the RV144 HIV vaccine efficacy trial","volume":"215","author":"Rerks-Ngarm","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"23","key":"10.1016\/j.micres.2025.128229_bib191","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Investigators M-T. vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N. Engl. J. Med"},{"issue":"7","key":"10.1016\/j.micres.2025.128229_bib192","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1073\/pnas.0630530100","article-title":"Rapid evolution of the neutralizing antibody response to HIV type 1 infection","volume":"100","author":"Richman","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.micres.2025.128229_bib193","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1473-3099(12)70088-9","article-title":"Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B\/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144","volume":"12","author":"Robb","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micres.2025.128229_bib194","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3389\/fimmu.2013.00498","article-title":"The significance of interferon-gamma in HIV-1 pathogenesis, therapy, and prophylaxis","volume":"4","author":"Roff","year":"2014","journal-title":"Front Immunol."},{"issue":"7420","key":"10.1016\/j.micres.2025.128229_bib195","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature11519","article-title":"Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2","volume":"490","author":"Rolland","year":"2012","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.micres.2025.128229_bib196","article-title":"Vaccination: A Historical Overview with a Focus on the Italian Achievements","volume":"14","author":"Romano LZanetti","year":"2022","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.micres.2025.128229_bib197","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jmb.2013.12.003","article-title":"Innate antiviral immune signaling, viral evasion and modulation by HIV-1","volume":"426","author":"Rustagi","year":"2014","journal-title":"J Mol Biol"},{"issue":"1-2","key":"10.1016\/j.micres.2025.128229_bib198","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cellimm.2015.10.009","article-title":"Regulation of CD8+\u2009T-cell cytotoxicity in HIV-1 infection","volume":"298","author":"Saeidi","year":"2015","journal-title":"Cell Immunol."},{"issue":"7","key":"10.1016\/j.micres.2025.128229_bib199","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1083\/jcb.201405051","article-title":"Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation","volume":"206","author":"Sainski","year":"2014","journal-title":"J. Cell Biol."},{"issue":"13","key":"10.1016\/j.micres.2025.128229_bib200","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1182\/blood-2007-06-097907","article-title":"CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+\u2009T cells to HIV-1 infection: a novel model of HIV-1 latency","volume":"110","author":"Saleh","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.micres.2025.128229_bib201","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies","volume":"9","author":"Sanders","year":"2013","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib202","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41541-021-00391-8","article-title":"Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines","volume":"6","author":"Sartorius","year":"2021","journal-title":"NPJ Vaccin."},{"issue":"51","key":"10.1016\/j.micres.2025.128229_bib203","doi-asserted-by":"crossref","first-page":"35237","DOI":"10.1074\/jbc.R114.619304","article-title":"Complexity of danger: the diverse nature of damage-associated molecular patterns","volume":"289","author":"Schaefer","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib204","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11904-016-0310-3","article-title":"NK Cells in HIV Disease","volume":"13","author":"Scully","year":"2016","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"4","key":"10.1016\/j.micres.2025.128229_bib205","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.celrep.2015.03.047","article-title":"Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design","volume":"11","author":"Sharma","year":"2015","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib206","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.biologicals.2015.10.004","article-title":"Review of efficacy trials of HIV-1\/AIDS vaccines and regulatory lessons learned: a review from a regulatory perspective","volume":"44","author":"Sheets","year":"2016","journal-title":"Biologicals"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib207","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12977-019-0491-0","article-title":"Effect of induced dNTP pool imbalance on HIV-1 reverse transcription in macrophages","volume":"16","author":"Shepard","year":"2019","journal-title":"Retrovirology"},{"issue":"12","key":"10.1016\/j.micres.2025.128229_bib208","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15122721","article-title":"30-year development of inactivated virus vaccine in China","volume":"15","author":"Shi","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib209","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cell.2016.05.055","article-title":"HIV-1 neutralizing antibodies with limited hypermutation from an Infant","volume":"166","author":"Simonich","year":"2016","journal-title":"Cell"},{"issue":"31","key":"10.1016\/j.micres.2025.128229_bib210","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1016\/j.vaccine.2023.06.029","article-title":"Optimizing the immunogenicity of HIV vaccines by adjuvants - NIAID workshop report","volume":"41","author":"Singh","year":"2023","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.micres.2025.128229_bib211","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008364","article-title":"An MHC-I cytoplasmic domain\/HIV-1 Nef fusion protein binds directly to the mu subunit of the AP-1 endosomal coat complex","volume":"4","author":"Singh","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.micres.2025.128229_bib212","first-page":"57","article-title":"Chapter Three - Technological advancements in viral vector designing and optimization for therapeutic applications","volume":"139","author":"Singh","year":"2024","journal-title":"Prajapati VK Editor. Adv. Protein Chem. Struct. Biol. Acad. Press"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib213","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1074\/jbc.M111.296772","article-title":"HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions","volume":"287","author":"Skasko","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib214","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/s41467-019-10262-5","article-title":"Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence","volume":"10","author":"Sliepen","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.micres.2025.128229_bib215","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1586\/14760584.2016.1129905","article-title":"HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies","volume":"15","author":"Sliepen KSanders","year":"2016","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib216","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.virusres.2012.06.015","article-title":"The origin of genetic diversity in HIV-1","volume":"169","author":"Smyth","year":"2012","journal-title":"Virus Res"},{"issue":"44","key":"10.1016\/j.micres.2025.128229_bib217","doi-asserted-by":"crossref","first-page":"15158","DOI":"10.1074\/jbc.REV120.012317","article-title":"Structure, function, and inhibitor targeting of HIV-1 Nef-effector kinase complexes","volume":"295","author":"Staudt","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.micres.2025.128229_bib218","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.immuni.2016.08.016","article-title":"HIV vaccine design to target germline precursors of glycan-dependent broadly neutralizing antibodies","volume":"45","author":"Steichen","year":"2016","journal-title":"Immunity"},{"issue":"6470","key":"10.1016\/j.micres.2025.128229_bib219","doi-asserted-by":"crossref","DOI":"10.1126\/science.aax4380","article-title":"A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses","volume":"366","author":"Steichen","year":"2019","journal-title":"Science"},{"issue":"6697","key":"10.1016\/j.micres.2025.128229_bib220","doi-asserted-by":"crossref","DOI":"10.1126\/science.adj8321","article-title":"Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates","volume":"384","author":"Steichen","year":"2024","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib221","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/viro.2000.0816","article-title":"HIV-1 Nef blocks transport of MHC class I molecules to the cell surface via a PI 3-kinase-dependent pathway","volume":"282","author":"Swann","year":"2001","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.micres.2025.128229_bib222","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.02198-21","article-title":"The HIV-1 viral protease is activated during assembly and budding prior to particle release","volume":"96","author":"Tabler","year":"2022","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib223","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41541-022-00503-y","article-title":"The use of viral vectors in vaccine development","volume":"7","author":"Travieso","year":"2022","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.micres.2025.128229_bib224","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.coi.2021.04.012","article-title":"Dynamics of MHC-I molecules in the antigen processing and presentation pathway","volume":"70","author":"Truong HVSgourakis","year":"2021","journal-title":"Curr Opin Immunol"},{"issue":"9","key":"10.1016\/j.micres.2025.128229_bib225","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1586\/erv.10.104","article-title":"Phase III HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV","volume":"9","author":"Vaccari","year":"2010","journal-title":"Expert Rev. Vaccin."},{"issue":"4-5","key":"10.1016\/j.micres.2025.128229_bib226","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cytogfr.2012.05.001","article-title":"The role of cytokines in the establishment, persistence and eradication of the HIV reservoir","volume":"23","author":"Vandergeeten","year":"2012","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.micres.2025.128229_bib227","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3389\/fimmu.2017.00580","article-title":"Pathophysiology of CD4+\u2009T-cell depletion in HIV-1 and HIV-2 infections","volume":"8","author":"Vidya Vijayan","year":"2017","journal-title":"Front Immunol."},{"issue":"25","key":"10.1016\/j.micres.2025.128229_bib228","doi-asserted-by":"crossref","first-page":"7214","DOI":"10.1016\/j.cell.2024.10.003","article-title":"Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.micres.2025.128229_bib229","doi-asserted-by":"crossref","first-page":"13799","DOI":"10.4238\/2015.October.28.42","article-title":"RIG-I detects HIV-1 infection and mediates type I interferon response in human macrophages from patients with HIV-1-associated neurocognitive disorders","volume":"14","author":"Wang","year":"2015","journal-title":"Genet Mol. Res"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib230","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-023-01408-5","article-title":"Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"5638","key":"10.1016\/j.micres.2025.128229_bib231","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.1086907","article-title":"Predominant autoantibody production by early human B cell precursors","volume":"301","author":"Wardemann","year":"2003","journal-title":"Science"},{"issue":"7256","key":"10.1016\/j.micres.2025.128229_bib232","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nature08237","article-title":"Architecture and secondary structure of an entire HIV-1 RNA genome","volume":"460","author":"Watts","year":"2009","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.micres.2025.128229_bib233","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.immuni.2023.10.002","article-title":"Single-cell epigenetic, transcriptional, and protein profiling of latent and active HIV-1 reservoir revealed that IKZF3 promotes HIV-1 persistence","volume":"56","author":"Wei","year":"2023","journal-title":"Immunity"},{"issue":"6929","key":"10.1016\/j.micres.2025.128229_bib234","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"Wei","year":"2003","journal-title":"Nature"},{"issue":"6510","key":"10.1016\/j.micres.2025.128229_bib235","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/373117a0","article-title":"Viral dynamics in human immunodeficiency virus type 1 infection","volume":"373","author":"Wei","year":"1995","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.micres.2025.128229_bib236","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.xphs.2019.01.033","article-title":"Developability assessment of physicochemical properties and stability profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 envelope glycoprotein trimers as candidate vaccine antigens","volume":"108","author":"Whitaker","year":"2019","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.micres.2025.128229_bib237","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.chom.2018.04.018","article-title":"Functional relevance of improbable antibody mutations for hiv broadly neutralizing antibody development","volume":"23","author":"Wiehe","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10.1016\/j.micres.2025.128229_bib238","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.immuni.2022.09.001","article-title":"Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors","volume":"55","author":"Willis","year":"2022","journal-title":"Immunity"},{"issue":"4949 Pt 1","key":"10.1016\/j.micres.2025.128229_bib239","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib240","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12943-023-01899-4","article-title":"Targeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects","volume":"22","author":"Wu","year":"2023","journal-title":"Mol. Cancer"},{"issue":"6697","key":"10.1016\/j.micres.2025.128229_bib241","doi-asserted-by":"crossref","DOI":"10.1126\/science.adk0582","article-title":"mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies","volume":"384","author":"Xie","year":"2024","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.micres.2025.128229_bib242","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41591-018-0042-6","article-title":"Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1","volume":"24","author":"Xu","year":"2018","journal-title":"Nat. Med"},{"issue":"8","key":"10.1016\/j.micres.2025.128229_bib243","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050775","article-title":"Understanding the interplay between dNTP metabolism and genome stability in cancer","volume":"17","author":"Yague-Capilla","year":"2024","journal-title":"Dis Model Mech"},{"issue":"5","key":"10.1016\/j.micres.2025.128229_bib244","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/cmi.2010.8","article-title":"The good and evil of complement activation in HIV-1 infection","volume":"7","author":"Yu","year":"2010","journal-title":"Cell Mol. Immunol."},{"issue":"2","key":"10.1016\/j.micres.2025.128229_bib245","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4049\/jimmunol.168.2.554","article-title":"Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines","volume":"168","author":"Zarember KAGodowski","year":"2002","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.micres.2025.128229_bib246","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12943-024-02156-y","article-title":"Regulatory T cells in immune checkpoint blockade antitumor therapy","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.micres.2025.128229_bib247","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1038\/s41591-021-01574-5","article-title":"A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques","volume":"27","author":"Zhang","year":"2021","journal-title":"Nat. Med"},{"issue":"7","key":"10.1016\/j.micres.2025.128229_bib248","doi-asserted-by":"crossref","first-page":"699","DOI":"10.18632\/oncotarget.27487","article-title":"DNA dependent protein kinase (DNA-PK) enhances HIV transcription by promoting RNA polymerase II activity and recruitment of transcription machinery at HIV LTR","volume":"11","author":"Zicari","year":"2020","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.micres.2025.128229_bib249","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1016\/S2352-3018(21)00073-4","article-title":"A tale of four studies: HIV vaccine immunogenicity and efficacy in clinical trials","volume":"8","author":"Zolla-Pazner","year":"2021","journal-title":"Lancet HIV"},{"issue":"5","key":"10.1016\/j.micres.2025.128229_bib250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10142-024-01425-9","article-title":"Clinical trials and recent progress in HIV vaccine development","volume":"24","author":"Zubair","year":"2024","journal-title":"Funct. Integr. Genom."}],"container-title":["Microbiological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944501325001855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944501325001855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T03:16:58Z","timestamp":1749007018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944501325001855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":250,"alternative-id":["S0944501325001855"],"URL":"https:\/\/doi.org\/10.1016\/j.micres.2025.128229","relation":{},"ISSN":["0944-5013"],"issn-type":[{"value":"0944-5013","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting HIV-1 immune escape mechanisms: Key advances and challenges in HIV-1 vaccine design","name":"articletitle","label":"Article Title"},{"value":"Microbiological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micres.2025.128229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"128229"}}